Cargando…

Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use

BACKGROUND: Patients with juvenile idiopathic arthritis (JIA) on non-steroidal anti- inflammatory drugs (NSAIDs) may experience abdominal pain. In adults, NSAID use has been linked to an increase in fecal calprotectin (FC) levels, a surrogate marker for gut inflammation. In JIA, data on gut inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aalto, Kristiina, Lahdenne, Pekka, Kolho, Kaija-Leena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286851/ https://www.ncbi.nlm.nih.gov/pubmed/28143478 http://dx.doi.org/10.1186/s12969-016-0132-2

Ejemplares similares

Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis
por: Nousiainen, Pauliina, et al.
Publicado: (2014)

Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
por: Kolho, Kaija-Leena, et al.
Publicado: (2013)

Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial
por: Tarkiainen, Maarit, et al.
Publicado: (2019)

Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis
por: Tarkiainen, Maarit, et al.
Publicado: (2022)

Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
por: Peltoniemi, Suvi Oili Orvokki, et al.
Publicado: (2023)

Perinatal risk factors for pediatric onset type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis, and inflammatory bowel diseases
por: Räisänen, Laura, et al.
Publicado: (2021)

Ongoing disease-activity and change in ILAR categories in a Nordic juvenile idiopathic arthritis cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Lahdenne, Pekka, et al.
Publicado: (2018)

Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)

Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis
por: Esbjörnsson, Anna-Clara, et al.
Publicado: (2014)

Serum Calprotectin a Potential Biomarker in Juvenile Idiopathic Arthritis: A Meta-Analysis
por: Altobelli, Emma, et al.
Publicado: (2021)

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
por: Tarkiainen, M, et al.
Publicado: (2008)

Measurement of blood calprotectin (MRP-8/MRP-14) levels in patients with juvenile idiopathic arthritis
por: Bojko, Jaryna
Publicado: (2017)

Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
por: Levälampi, Tiina, et al.
Publicado: (2023)

The Increased Levels of Fecal Calprotectin in Children With Active Enthesitis Related Arthritis and MRI Signs of Sacroiliitis: The Results of a Single Center Cross-Sectional Exploratory Study in Juvenile Idiopathic Arthritis Patients
por: Lamot, Lovro, et al.
Publicado: (2021)

Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment
por: Boyko, Yaryna, et al.
Publicado: (2020)

Fecal Calprotectin as a Future Screening Tool for Large Juvenile Polyps
por: Khan, Farah, et al.
Publicado: (2015)

Juvenile Polyps in Bangladeshi Children and Their Association with Fecal Calprotectin as a Biomarker
por: Das, Subarna Rani, et al.
Publicado: (2022)

Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience
por: Mikola, Katriina, et al.
Publicado: (2022)

Trends in Early Outpatient Drug Therapy in Pediatric Inflammatory Bowel Disease in Finland: A Nationwide Register-Based Study in 1999–2009
por: Virta, Lauri J., et al.
Publicado: (2012)

Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
por: Öman, Anders, et al.
Publicado: (2021)

Juvenile arthritis disease activity score (JADAS) based on C-reactive protein predicts DMARD treatment in juvenile idiopathic arthritis in a Nordic multicenter cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study
por: d’Angelo, Debora Mariarita, et al.
Publicado: (2023)

Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
por: Boom, V., et al.
Publicado: (2015)

Fecal calprotectin measurement to detect recurrence of solitary juvenile polyps: A case report
por: Kudoh, Maika, et al.
Publicado: (2023)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study
por: Ekelund, Maria, et al.
Publicado: (2017)

Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis
por: Backström, Maria, et al.
Publicado: (2019)

Prognostic factors for the disease course and 8-year outcome in Nordic children with oligoarticular-onset juvenile idiopathic arthritis
por: Peltoniemi, Suvi, et al.
Publicado: (2014)

Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study
por: Nordal, Ellen, et al.
Publicado: (2017)

Protocol for oral transplantation of maternal fecal microbiota to newborn infants born by cesarean section
por: Helve, Otto, et al.
Publicado: (2021)

Fecal Calprotectin Levels Significantly Correlate with Polyp Size in Children and Adolescents with Juvenile Colorectal Polyps
por: Kim, Yu Bin, et al.
Publicado: (2023)

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis
por: Trincianti, Chiara, et al.
Publicado: (2021)

Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy
por: Sidoroff, Marianne, et al.
Publicado: (2014)

Share – Workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile idiopathic arthritis
por: Vastert, Sebastiaan, et al.
Publicado: (2014)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

The role of fecal calprotectin in pediatric disease
por: Jeong, Su Jin
Publicado: (2019)

An extended catalog of integrated prophages in the infant and adult fecal microbiome shows high prevalence of lysogeny
por: Dikareva, Evgenia, et al.
Publicado: (2023)

Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

Juvenile idiopathic arthritis
por: Bhatt, Krupa H, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4iqi04jen891sf3uu3jt96h4um